Cefotaxime, the - syn - derivative of 7 - [(2-(2-amino-4-4-thiazolyl)-2-methoxyimino) acetamido] cephalosporanic acid, is a new semisynthetic cephalosporin. In in vitro studies, it was 80 times more active than the - anti - derivative against beta-lactamase-producing strains of Gram-negative bacteria. The range of inhibitory concentrations of cefotaxime against Gram-negative bacteria, including Haemophilus influenzae, susceptible or resistant to penicillins and cephalosporins was from 0.01 to 0.1 micrograms/ml. This activity was consistently higher than that observed with cephalothin, cephaloridine, cephalexin, and cefazolin. Nevertheless, some strains of Enterobacter cloacae were resistant. Cefotaxime showed very similar activity to that of ampicillin against group A streptococci and Streptococcus pneumoniae.

Download full-text PDF

Source

Publication Analysis

Top Keywords

gram-negative bacteria
8
[cefotaxime syn
4
syn isomer
4
isomer methoxyimino
4
methoxyimino cephalosporin
4
cephalosporin unusual
4
unusual activity
4
activity author's
4
author's transl]
4
transl] cefotaxime
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!